Showing results (351-360 of 491) with videos related to

Sort By:
Pageof 50
Diabetes|January 21, 2022
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE TrialEmil Wolsk, Mikkel Jürgens, Morten Schou, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 22, 2022
Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish CohortQuenia Dos Santos, Mads Hornum, Cynthia Terrones-Campos, et al.
International Journal of Cardiology|January 3, 2024
Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH studyCasper Lund-Andersen, Adelina Yafasova, Dan Høfsten, et al.
JACC. Cardiovascular Interventions|January 14, 2026
Clinical Application of Guideline-Directed Medical Therapy in TAVR Patients With Heart Failure and Reduced Ejection FractionYusuke Kobari, Annette Maznyczka, Arif A Khokhar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection FractionMassar Omar, Jesper Jensen, Peter H Frederiksen, et al.
ESC Heart Failure|February 19, 2026
Effects of Empagliflozin on Right Ventricular Free-Wall Strain in Patients with Heart Failure and Reduced Ejection FractionMassar Omar, Jesper Jensen, Mulham Ali, et al.
International Journal of Cardiology|April 19, 2022
Rate of thromboembolic and bleeding events in patients undergoing concomitant aortic valve surgery with left ventricular assist device implantationYunus C Yalcin, Jesse F Veenis, Jasper J Brugts, et al.
Circulation|February 19, 2019
Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in ScandinaviaKari Nytrøen, Katrine Rolid, Arne Kristian Andreassen, et al.
Lancet (London, England)|March 31, 2016
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trialGerd Hasenfuß, Chris Hayward, Dan Burkhoff, et al.
ESC Heart Failure|November 1, 2018
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge periodGerhard Pölzl, Shadab Allipour Birgani, Josep Comín-Colet, et al.
Pageof 50